Back to Search

NATCOPHARM

NSEHealthcareCap: ₹15348.18 Cr

NATCO Pharma Ltd.

-11.62%YTD

Non-Compliant (Not Permissible)

Evaluated using MSCI criteria

Reasons for Non-Compliance:
  • Impure Revenue: Non-permissible income 5.72% exceeds limit 5.0%.

Market Fundamentals

Live NSE/BSE
Market Cap
₹15348.18 Cr
P/E Ratio
12.3x
P/B Ratio
1.5x
52W High
₹1,226.8
52W Low
₹773.6
Div. Yield
76.00%
Shares O/S
19.62 Cr

Where Does the Money Come From?

Revenue breakdown for NATCO Pharma Ltd.

Core Healthcare OperationsPermissible Operating Activity

Permissible: Core operations in Healthcare.

94.3%of Total Revenue
Treasury Interest & Secondary Non-Operating IncomeImpure Interest Income (Riba)

Non-operating interest income earned from cash and fixed deposits. Requires purification.

5.7%of Total Revenue
About NATCO Pharma Ltd.

Permissible: Core operations in Healthcare.

Interest-Bearing Debt Ratio
6.45%Max: ≤ 33.0%
Cash & Securities Liquidity
25.18%Max: ≤ 33.0%
Impure Revenue Ratio
5.72%Max: ≤ 5.0%
Screening Denominator
Total Assets

Purification & Zakat Calculator

Calculate how much to donate for NATCOPHARM

⚠️ Note: NATCOPHARM is not Halal. The right step is to sell this stock, not just purify the dividends. Keeping a non-compliant investment is not resolved by Sadaqah.